High prevalence of methicillin-resistant Staphylococcus aureus with SCCmec type III in cystic fibrosis patients in southern, Brazil;Alta prevalência de Staphylococcus aureus resistente à meticilina com SCCmec tipo III em pacientes com fibrose cística no Sul do Brasil

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 43, Issue 4, 2010, Pages 377-381

  Reiter, Keli Cristine ^a   Machado, Alice Beatriz Mombach Pinheiro ^b   de Freitas, Ana Lúcia Peixoto ^a   Barth, Afonso Luís ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Cystic fibrosis; MRSA; Multiresistance; SCCmec

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; CHLORAMPHENICOL; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; PROTEIN SCCMEC TYPE III; RIFAMPICIN; SULFATRIMETHOPRIM; UNCLASSIFIED DRUG;

ACHROMOBACTER XYLOSOXIDANS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BRAZIL; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; GENE CASSETTE; HUMAN; KLEBSIELLA OXYTOCA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR TYPING; NONHUMAN; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS FLUORESCENS; SERRATIA; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 77957975321     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822010000400008     Document Type: Article

References (17)

1. Mainz Jg, Naehrlich L, Schien M, Kading M, Schiller I, Mayr S, et al. Concordant genotype of upper and lower airways P. aeruginosa and S. aureus isolates in cystic fibrosis. Thorax2009; 64:535-540.
2. Vergison A, Denis O, Deplano A, Casimir g, Claeys g DeBaets F, et al. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. J Antimicrob Chemother 2007; 59:893-899.
3. Sawicki gS, Rasouliyan L, Pasta DJ, Regelmann WE, Wagener JS, Waltz DA, et al. The impact of incident methicillin-resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis. Pediatr Pulmonol2008; 43:1117-1123.
4. Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev 2004; 17:57-71.
5. Molina A, Del Campo R, Máiz L, Morosini MI, Lamas A, Baquero F, et al. High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation. J Antimicrob Chemother 2008; 62:961-967.
6. Kahl BC, Duebbers A, Lubritz g, Haeberle J, Koch Hg, Ritzerfeld B, et al. Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study. J Clin Microbiol 2003; 41:4424-4427.
7. Prunier AL, Malbruny B, Laurans M, Brouard J, Duhamel JF, Leclercq R. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J Infect Dis 2003; 187:1709-1716.
8. garcýa-Castillo M, Morosini MI, Valverde A, Almaraz F, Baquero F, Cantón R, et al. Differences in biofilm development and antibiotic susceptibility among Streptococcus pneumoniae isolates from cystic fibrosis samples and blood cultures. J Antimicrob Chemother 2007; 59:301-304.
9. Elizur A, Orscheln RC, Ferkol TW, Atkinson JJ, Dunne WM, Buller RS, et al. Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest 2007; 131:1718-1725.
10. Wayne PA. Performance standards for antimicrobial susceptibility testing. In: Informational Supplement M100-S16. Clinical and Laboratory Standards Institute; 2008.
11. Zhang K, McClure J, Elsayed S, Louie T, Conly JM. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005; 43:5026-5033.
12. Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aureus. Infect Gen Evol 2008; 8:747-763.
13. Millar FA, Simmonds NJ, Hodson ME. Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985-2005. J Cyst Fibros2009; 8:386-391.
14. Razvi S, Quittell L, Sewall A, Quinton H, Marshall B, Saiman L. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest2009; 136:1554-1560.
15. goodrich JS, Sutton-Shields TN, Kerr A, Wedd JP, Miller MB,gilligan PH. Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol2009; 47:1231-1233.
16. Ito T, Okuma K, Ma XX, Yuzawa H, Hiramatsu K. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Updat 2003; 6:41-52.
17. girón RM, Buendía B, Pinedo C, Casanova A, Hoyos N, Ancochea J. Methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. Enferm Infec Microbiol Clin2009; 27:85-88.